日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary

索托拉西布与多西他赛治疗既往接受过治疗的KRAS G12C突变型非小细胞肺癌:简明扼要的总结

de Langen, Adrianus Johannes; Johnson, Melissa L; Mazieres, Julien; Dingemans, Anne-Marie C; Mountzios, Giannis; Pless, Miklos; Wolf, Jürgen; Schuler, Martin; Lena, Hervé; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J; Ramalingam, Suresh S; Dooms, Christophe; Lindsay, Colin R; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Björn; Waterhouse, David; Paz-Ares, Luis

Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer

Sotorasib治疗KRAS p.G12C突变型晚期胰腺癌

Strickler, John H; Satake, Hironaga; George, Thomas J; Yaeger, Rona; Hollebecque, Antoine; Garrido-Laguna, Ignacio; Schuler, Martin; Burns, Timothy F; Coveler, Andrew L; Falchook, Gerald S; Vincent, Mark; Sunakawa, Yu; Dahan, Laetitia; Bajor, David; Rha, Sun-Young; Lemech, Charlotte; Juric, Dejan; Rehn, Marko; Ngarmchamnanrith, Gataree; Jafarinasabian, Pegah; Tran, Qui; Hong, David S

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

索托拉西布治疗KRAS p.G12C突变型肺癌

Skoulidis, Ferdinandos; Li, Bob T; Dy, Grace K; Price, Timothy J; Falchook, Gerald S; Wolf, Jürgen; Italiano, Antoine; Schuler, Martin; Borghaei, Hossein; Barlesi, Fabrice; Kato, Terufumi; Curioni-Fontecedro, Alessandra; Sacher, Adrian; Spira, Alexander; Ramalingam, Suresh S; Takahashi, Toshiaki; Besse, Benjamin; Anderson, Abraham; Ang, Agnes; Tran, Qui; Mather, Omar; Henary, Haby; Ngarmchamnanrith, Gataree; Friberg, Gregory; Velcheti, Vamsidhar; Govindan, Ramaswamy

KRAS(G12C) Inhibition with Sotorasib in Advanced Solid Tumors

索托拉西布抑制KRAS(G12C)治疗晚期实体瘤

Hong, David S; Fakih, Marwan G; Strickler, John H; Desai, Jayesh; Durm, Gregory A; Shapiro, Geoffrey I; Falchook, Gerald S; Price, Timothy J; Sacher, Adrian; Denlinger, Crystal S; Bang, Yung-Jue; Dy, Grace K; Krauss, John C; Kuboki, Yasutoshi; Kuo, James C; Coveler, Andrew L; Park, Keunchil; Kim, Tae Won; Barlesi, Fabrice; Munster, Pamela N; Ramalingam, Suresh S; Burns, Timothy F; Meric-Bernstam, Funda; Henary, Haby; Ngang, Jude; Ngarmchamnanrith, Gataree; Kim, June; Houk, Brett E; Canon, Jude; Lipford, J Russell; Friberg, Gregory; Lito, Piro; Govindan, Ramaswamy; Li, Bob T

Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors

AMG 337(一种高选择性小分子MET抑制剂)治疗晚期实体瘤患者的I期研究

Hong, David S; LoRusso, Patricia; Hamid, Omid; Janku, Filip; Kittaneh, Muaiad; Catenacci, Daniel V T; Chan, Emily; Bekaii-Saab, Tanios; Gadgeel, Shirish M; Loberg, Robert D; Amore, Benny M; Hwang, Yuying C; Tang, Rui; Ngarmchamnanrith, Gataree; Kwak, Eunice L

Clinical Implications and Translation of an Off-Target Pharmacology Profiling Hit: Adenosine Uptake Inhibition In Vitro

脱靶药理学分析发现的临床意义及转化:体外腺苷摄取抑制

Amouzadeh, Hamid R; Dimery, Isaiah; Werner, Jonathan; Ngarmchamnanrith, Gataree; Engwall, Michael J; Vargas, Hugo M; Arrindell, Deborah

Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumors

剂量递增结果来自一项针对晚期实体瘤患者的糖皮质激素诱导型TNF受体相关蛋白激动剂AMG 228的首次人体I期研究。

Tran, Ben; Carvajal, Richard D; Marabelle, Aurelien; Patel, Sandip Pravin; LoRusso, Patricia M; Rasmussen, Erik; Juan, Gloria; Upreti, Vijay V; Beers, Courtney; Ngarmchamnanrith, Gataree; Schöffski, Patrick

A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors

口服 MET 抑制剂 AMG 208 对晚期实体瘤成年患者进行的首次人体研究

David S Hong, Peter Rosen, A Craig Lockhart, Siqing Fu, Filip Janku, Razelle Kurzrock, Rabia Khan, Benny Amore, Isaac Caudillo, Hongjie Deng, Yuying C Hwang, Robert Loberg, Gataree Ngarmchamnanrith, Darrin M Beaupre, Peter Lee